Unlock 30% off global market reports with code ONLINE30 – get insights on tariff changes, macro trends, and global economic shifts.
What is the anticipated market size of the airway stent industry over the next few years?
The airway stent market size has grown strongly in recent years. It will grow from $9.98 billion in 2024 to $10.73 billion in 2025 at a compound annual growth rate (CAGR) of 7.5%. The growth in the historic period can be attributed to the rising incidence of respiratory diseases, improved diagnostic techniques, a growing aging population, increased awareness and healthcare access, and growth in surgical and interventional procedures.
The airway stent market size is expected to see strong growth in the next few years. It will grow to $14.2 billion in 2029 at a compound annual growth rate (CAGR) of 7.3%. The growth in the forecast period can be attributed to aging population growth, growing healthcare infrastructure, rising emphasis on managing chronic respiratory conditions, rising awareness of respiratory health, and growth in outpatient and ambulatory procedures. Major trends in the forecast period include technological advancements, minimally invasive procedures, advancements in medical technology, bioresorbable stents, and advanced self-expanding materials.
Download Your Free Sample PDF:
What emerging drivers are expected to shape the future of the airway stent market?
The increasing prevalence of lung diseases and respiratory disorders is expected to propel the growth of the airway stent market going forward. Lung diseases and respiratory disorders refer to a broad range of conditions affecting the lungs and respiratory system, impairing breathing and overall lung function. The increasing prevalence of lung diseases and respiratory disorders is driven by factors such as rising pollution levels, smoking habits, exposure to environmental toxins, and the aging population. Additionally, lifestyle changes and genetic predispositions contribute to the growing incidence of these health conditions. Airway stents are used in the increasing prevalence of lung diseases and respiratory disorders to provide structural support to the airways, alleviate obstruction, and improve airflow in patients with conditions such as tracheal stenosis or bronchial tumors. For instance, in May 2024, according to data from the National Center for Health Statistics (NCHS), a U.S.-based health statistics agency, the prevalence of current asthma among adults aged 18 and over in the United States increased from 8.4% in 2021 to 8.7% in 2022. Furthermore, asthma episodes within the past 12 months for the same age group rose from 3.3% in 2021 to 3.7% in 2022. Therefore, the increasing prevalence of lung diseases and respiratory disorders will drive the growth of the airway stent market.
What emerging segments are shaping the future landscape of the airway stent industry?
The airway stent market covered in this report is segmented –
1) By Type: Tracheal Stents, Laryngeal Stents, Bronchial stents
2) By Product Type: Expandable Stents, Non-Expandable Stents
3) By Material Type: Metal, Silicone, Hybrid
4) By End-User: Hospitals, Clinics, Home Healthcare, Ambulatory Surgical Centers, Laboratories, Research Facilities
Subsegments:
1) By Tracheal Stents: Silicone Tracheal Stents, Metallic Tracheal Stents, Hybrid Tracheal Stents
2) By Laryngeal Stents: Silicone Laryngeal Stents, Self-Expanding Laryngeal Stents, Biodegradable Laryngeal Stents
3) By Bronchial Stents: Metallic Bronchial Stents, Silicone Bronchial Stents, Covered Bronchial Stents, Self-Expanding Bronchial Stents
View The Full Market Report:
What are the most notable trends influencing investment in the airway stent sector?
Major companies operating in the airway stent market are focusing on technological advancements such as the self-expanding Y-shaped stent system to improve patient outcomes and address complex airway conditions more effectively. The self-expanding Y-shaped stent system is a medical device designed to support and maintain airway patency in patients with tracheal or bronchial stenosis, offering a tailored fit that expands automatically to match the anatomy of the airways. For instance, in February 2022, Micro-Tech Endoscopy, a US-based provider of advanced endoscopic solutions specializing in innovative medical devices for minimally invasive procedures, launched the first self-expanding tracheobronchial nitinol Y-stent, designed to enhance the treatment of malignant neoplasms at the tracheobronchial carina. This Y-shaped Tracheal Stent System features a low-profile delivery system for optimal ventilation and visualization during placement, a silicone cover to prevent tumor ingrowth, and repositioning sutures for easy adjustment or removal. Its flexible, compliant design and nitinol self-expanding technology effectively relieve patients with malignant tracheobronchial strictures, ensuring improved deployment and patient outcomes.
How are key players in the airway stent market strengthening their market position?
Major companies operating in the airway stent market are Medtronic Plc, Stryker Corporation, Boston Scientific Corporation, Olympus Corporation, Teleflex Incorporated, Cook Medical, KARL STORZ SE & Co. KG, Merit Medical Systems, MICRO-TECH (Nanjing) Co. Ltd., Taewoong Medical Co. Ltd., Alvimedica Medical Technologies Inc, M.I. Tech Co. Ltd., Fuji Systems Corporation, Pnn Medical A/S, Endo-Flex GmbH, InSitu Technologies, QualiMed Innovative Medizinprodukte GmbH, Novatech SA, Boston Medical Products Inc., HOOD LABORATORIES, Meditek Systems Pvt. Ltd., Kapitex Healthcare Ltd, S&G Biotech Inc., AndraTec GmbH, Allium Medical Solutions Ltd., Medi-Globe GmbH, Bess medizintechnik GmbH
Which geographic areas are contributing significantly to the growth of the airway stent sector?
North America was the largest region in the airway stent market in 2024. Asia-Pacific is expected to be the fastest-growing region in the forecast period. The regions covered in the airway stent market report are Asia-Pacific, Western Europe, Eastern Europe, North America, South America, Middle East, Africa.
How Can Companies Use The Airway Stent Market Report to Drive Business Results?
This report provides actionable insights tailored for business use—not academic analysis. Companies can leverage the data to:
• Time market entry or expansion using growth forecasts and CAGR trends.
• Develop competitive products by tracking key technology shifts and user preferences.
• Tailor regional strategies with in-depth geographic data and local market dynamics.
• Benchmark and plan partnerships using competitive landscape insights.
Purchase The Report And Get A Swift Delivery:
Need Customized Data On Airway Stent Market?
For companies needing more tailored intelligence, The Business Research Company offers customized consulting and data services. Whether you're entering new regions, launching innovative products, or assessing M&A opportunities, our experts can develop actionable insights specific to your business objectives.
Request Customized Data:
About The Business Research Company:
With over 15000+ reports from 27 industries covering 60+ geographies, The Business Research Company has built a reputation for offering comprehensive, data-rich research and insights. Armed with 1,500,000 datasets, the optimistic contribution of in-depth secondary research, and unique insights from industry leaders, you can get the information you need to stay ahead.
Our flagship product, the Global Market Model, is a premier market intelligence platform delivering comprehensive and updated forecasts to support informed decision-making.
Contact Us:
The Business Research Company
Americas +1 310-496-7795
Asia +44 7882 955267 & +91 8897263534
Europe +44 7882 955267
Email us at info@tbrc.info
Follow Us On:
LinkedIn: The Business Research Company | LinkedIn
Comments
Post a Comment